SI-BONE, INC. Proceeds from Long-Term Debt Issued
SI-BONE, INC. (SIBN) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-24
- SI-BONE, INC. proceeds from issuance of long-term debt for the quarter ending 2024-12-31 was $35.95M.
- SI-BONE, INC. proceeds from issuance of long-term debt for the quarter ending 2024-09-30 was $0.00.
- SI-BONE, INC. proceeds from issuance of long-term debt for the quarter ending 2024-06-30 was $0.00.
- SI-BONE, INC. proceeds from issuance of long-term debt for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SI-BONE, INC. proceeds from issuance of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SI-BONE, INC. proceeds from issuance of long-term debt for fiscal 2024 was $35.95M, a 0.02% decline from fiscal 2023.
- SI-BONE, INC. proceeds from issuance of long-term debt for fiscal 2023 was $35.96M.
- SI-BONE, INC. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month | Proceeds from Issuance of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | ||||
| 2024-12-31 | $35.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $35.95M derived: sum of 2 quarters · filed 2026-02-24 | $35.95M derived: sum of 3 quarters · filed 2026-02-24 | $35.95M 10-K · filed 2026-02-24 | $36.00M 10-K · filed 2025-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$40.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | -$40.00K derived: sum of 3 quarters · filed 2026-02-24 | -$40.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | -$40.00K derived: sum of 2 quarters · filed 2026-02-24 | -$40.00K derived: sum of 3 quarters · filed 2026-02-24 | -$40.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$40.00K derived: sum of 2 quarters · filed 2026-02-24 | -$40.00K derived: sum of 3 quarters · filed 2026-02-24 | $35.96M 10-K · filed 2026-02-24 | $36.00M 10-K · filed 2024-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $36.00M 10-Q · filed 2024-11-12 | $36.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $36.00M 10-Q · filed 2024-08-06 | $36.00M derived: sum of 3 quarters · filed 2025-02-25 | $36.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $36.00M 10-Q · filed 2024-05-07 | $36.00M derived: sum of 2 quarters · filed 2025-02-25 | $36.00M derived: sum of 3 quarters · filed 2025-02-25 | $36.00M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $35.00M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 | $0.00 derived: sum of 2 quarters · filed 2023-05-02 | $35.00M derived: sum of 3 quarters · filed 2023-05-02 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $35.00M derived: sum of 2 quarters · filed 2023-03-02 | $35.00M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $35.00M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $45.30M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $45.30M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $45.30M 10-Q · filed 2021-08-04 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $0.00 derived: sum of 2 quarters · filed 2021-03-10 | $0.00 10-K · filed 2021-03-10 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $0.00 10-Q · filed 2020-11-03 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-04 | ||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | ||||
| 2017-12-31 | $40.00M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |